News and Events

April 20, 2016,

Starbeam Study Update

On April 20th, 2016, ALD Connect chair, Dr.Florian Eichler, presented bluebird bio’s gene therapy study results. bluebird bio press release: bluebird bio Reports Interim Clinical Data from Starbeam Study of Lenti-D at AAN 2016 Annual Meeting

Xconomy also released an article on the study on April 20th: Bluebird’s Gene Therapy Shows Promise in Rare Brain Disease